SPONSOR
Rennes University Hospital
Total Trials
10
Recruiting
10
Phases
Phase 3, Phase 1, Phase 4
Conditions studied: Multiple SclerosisRelapsing-remitting Multiple SclerosisHead Injury TraumaEmergenciesHemiparesis/Hemiplegia (One Sided Weakness/Paralysis)Gait DisorderAlzheimer Disease, Early OnsetPAD - Peripheral Arterial DiseaseLumbar Spinal StenosisLower Limb Arterial Disease
Rennes University Hospital is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Multiple Sclerosis, Relapsing-remitting Multiple Sclerosis, Head Injury Trauma, Emergencies.
The trial portfolio spans Phase 3, Phase 1, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Rennes University Hospital
How many clinical trials has Rennes University Hospital sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by Rennes University Hospital, of which 10 are actively recruiting participants. These trials cover conditions including Multiple Sclerosis, Relapsing-remitting Multiple Sclerosis, Head Injury Trauma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Rennes University Hospital research focus on?
Rennes University Hospital clinical trials span Multiple Sclerosis, Relapsing-remitting Multiple Sclerosis, Head Injury Trauma, Emergencies, Hemiparesis/Hemiplegia (One Sided Weakness/Paralysis), and additional conditions. The research pipeline includes Phase 3, Phase 1, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Rennes University Hospital clinical trial?
To participate in a Rennes University Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Rennes University Hospital trials with current recruitment status updated daily.
Clinical Trials by Rennes University Hospital
NCT05758831 Phase 3
Recruiting
RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.
Multiple Sclerosis
NCT06592703 Phase 1
Recruiting
Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis
Multiple Sclerosis
NCT03687528
Recruiting
Platelet Inhibitor Treated Patients With Head Injury Trauma Meeting NICE Criteria : is the CT-scan Mandatory ?
Head Injury Trauma
NCT05887440
Recruiting
Isokinetic Strength Training in Hemiparetic Patient With Knee Extension Thrust
Hemiparesis/Hemiplegia (One Sided Weakness/Paralysis)
NCT06099587
Recruiting
MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease
Alzheimer Disease, Early Onset
NCT07469020
Recruiting
CLE-PAD : Prevalence of PAD in Patients With Surgically Lumbar Spinal Stenosis
PAD - Peripheral Arterial Disease
NCT07202897 Phase 3
Recruiting
LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain.
Hypertrophic Cardiomyopathy (HCM)
NCT06898099
Recruiting
Evaluation of the Efficacy of E2R Hypnotherapy in the Management of Chronic Insomnia in Primary Care (HypERR)
Chronic Insomnia
NCT05726305
Recruiting
Transplantation of Uterus for Uterine infertiLIty From Living Donor or Deceased Donor
Uterine Factor Infertility
NCT06535945 Phase 4
Recruiting
Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation
Liver Transplantation
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology